Powderhorn , 1 month ago Worth noting: this is 90% effective for HSV-1, but not tested on HSV-2. That's on their radar for research. It's nonetheless a breakthrough, and the Hutch has pulled off some interesting things in the past, so I'd imagine they'll get there.
Worth noting: this is 90% effective for HSV-1, but not tested on HSV-2. That's on their radar for research. It's nonetheless a breakthrough, and the Hutch has pulled off some interesting things in the past, so I'd imagine they'll get there.